UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Capital Management Associates Inc

Capital Management Associates Inc cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,322 shares of the healthcare conglomerate’s stock after selling 230 shares during the quarter. UnitedHealth Group accounts for 0.8% of Capital Management Associates Inc’s holdings, making the stock its 22nd largest holding. Capital Management Associates Inc’s holdings in UnitedHealth Group were worth $2,186,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in UNH. AMF Tjanstepension AB lifted its stake in UnitedHealth Group by 88.0% during the third quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock worth $151,374,000 after purchasing an additional 121,180 shares during the last quarter. Hudson Value Partners LLC boosted its holdings in UnitedHealth Group by 8.3% in the 3rd quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock valued at $625,000 after purchasing an additional 82 shares in the last quarter. Wealth Group Ltd. grew its position in UnitedHealth Group by 4.0% during the third quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock worth $1,039,000 after buying an additional 68 shares during the period. Sendero Wealth Management LLC increased its holdings in UnitedHealth Group by 1.4% during the 3rd quarter. Sendero Wealth Management LLC now owns 2,692 shares of the healthcare conglomerate’s stock valued at $1,574,000 after acquiring an additional 37 shares in the last quarter. Finally, Tobam raised its stake in UnitedHealth Group by 22.7% in the 3rd quarter. Tobam now owns 2,320 shares of the healthcare conglomerate’s stock valued at $1,356,000 after purchasing an additional 429 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $526.68 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market cap of $484.69 billion, a P/E ratio of 33.98, a PEG ratio of 1.45 and a beta of 0.61. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The firm’s 50 day moving average price is $530.85 and its two-hundred day moving average price is $564.52.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the previous year, the company earned $5.83 earnings per share. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Activity

In related news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. KeyCorp reissued an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Truist Financial reduced their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Barclays reduced their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Finally, Royal Bank of Canada lowered their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.